(KER) Kering - Overview
Sector: Consumer CyclicalIndustry: Luxury Goods | Exchange PA (France) | Currency EUR | Market Cap: 35.678m | Total Return 37.9% in 12m
Stock
Fashion, Leather, Jewelry, Eyewear, Beauty
Total Rating 64
Risk 78
Buy Signal -0.25
Market Cap:
35,678m
Avg Trading Vol: 65.7M EUR
Avg Trading Vol: 65.7M EUR
ATR:
3.97%
Peers RS (IBD): 69.6
Peers RS (IBD): 69.6
Risk 5d forecast
Volatility42.5%
Rel. Tail Risk-13.7%
Reward TTM
Sharpe Ratio1.06
Alpha26.23
Character TTM
Beta0.781
Beta Downside1.090
Drawdowns 3y
Max DD71.30%
CAGR/Max DD-0.31
Description: KER Kering
February 28, 2026
Kering SA (ticker KER) is a French luxury conglomerate that designs, manufactures and markets a portfolio of high-end fashion, leather goods, jewelry and beauty brands-including Gucci, Saint Laurent, Bottega Veneta, Balenciaga and Alexander McQueen-across Asia-Pacific, Western Europe, North America, Japan and other global markets.
In FY 2023 the group generated €19.8 billion in revenue, up 13% year-on-year, with an operating margin of 17.6% driven by strong demand for leather goods in Asia-Pacific (+12% YoY) and robust digital sales growth (e-commerce now accounts for 23% of total sales). The luxury sector is projected to expand at a 5% CAGR through 2027, supported by rising affluent consumer spending and continued brand-level investments in sustainability and omnichannel experiences.
For a deeper dive into Kering’s valuation and outlook, you might explore additional analysis on ValueRay.
- Gucci brand performance significantly impacts overall revenue and profitability
- Luxury consumer spending trends affect demand across all brands
- Currency fluctuations influence international sales and profit margins
- Supply chain disruptions increase production costs and limit product availability
- Regulatory changes in key markets impact brand operations and sales
Piotroski VR‑10 (Strict, 0-10)
6.0
| Net Income: 1.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.12 > 1.0 |
| NWC/Revenue: 8.49% < 20% (prev 11.00%; Δ -2.51% < -1%) |
| CFO/TA 0.16 > 3% & CFO 6.68b > Net Income 1.21b |
| Net Debt (19.28b) to EBITDA (11.19b): 1.72 < 3 |
| Current Ratio: 1.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (122.9m) vs 12m ago 0.39% < -2% |
| Gross Margin: 73.24% > 18% (prev 0.76%; Δ 7.25k% > 0.5%) |
| Asset Turnover: 77.21% > 50% (prev 72.49%; Δ 4.72% > 0%) |
| Interest Coverage Ratio: 5.62 > 6 (EBITDA TTM 11.19b / Interest Expense TTM 1.25b) |
Altman Z''
2.80
| A: 0.07 (Total Current Assets 10.76b - Total Current Liabilities 8.05b) / Total Assets 41.18b |
| B: 0.36 (Retained Earnings 14.90b / Total Assets 41.18b) |
| C: 0.17 (EBIT TTM 7.03b / Avg Total Assets 41.27b) |
| D: 0.05 (Book Value of Equity 1.16b / Total Liabilities 25.67b) |
| Altman-Z'' Score: 2.80 = A |
Beneish M
-2.96
| DSRI: 1.07 (Receivables 1.31b/1.15b, Revenue 31.87b/29.99b) |
| GMI: 1.04 (GM 73.24% / 75.86%) |
| AQI: 1.12 (AQ_t 0.52 / AQ_t-1 0.46) |
| SGI: 1.06 (Revenue 31.87b / 29.99b) |
| TATA: -0.13 (NI 1.21b - CFO 6.68b) / TA 41.18b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of KER shares?
As of March 31, 2026, the stock is trading at EUR 256.50 with a total of 220,666 shares traded.
Over the past week, the price has changed by +4.61%, over one month by -10.28%, over three months by -14.30% and over the past year by +37.87%.
Over the past week, the price has changed by +4.61%, over one month by -10.28%, over three months by -14.30% and over the past year by +37.87%.
Is KER a buy, sell or hold?
Kering has no consensus analysts rating.
What are the forecasts/targets for the KER price?
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 294.5 | 14.8% |
| Analysts Target Price | - | - |
KER Fundamental Data Overview
March 28, 2026
Market Cap USD = 35.68b (30.92b EUR * 1.1537 EUR.USD)P/E Forward = 32.5733
P/S = 2.1073
P/B = 1.9524
P/EG = 0.9355
Revenue TTM = 31.87b EUR
EBIT TTM = 7.03b EUR
EBITDA TTM = 11.19b EUR
Long Term Debt = 10.31b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.23b EUR (from shortTermDebt, last quarter)
Debt = 23.60b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 19.28b EUR (from netDebt column, last quarter)
Enterprise Value = 50.21b EUR (30.92b + Debt 23.60b - CCE 4.31b)
Interest Coverage Ratio = 5.62 (Ebit TTM 7.03b / Interest Expense TTM 1.25b)
EV/FCF = 16.36x (Enterprise Value 50.21b / FCF TTM 3.07b)
FCF Yield = 6.11% (FCF TTM 3.07b / Enterprise Value 50.21b)
FCF Margin = 9.63% (FCF TTM 3.07b / Revenue TTM 31.87b)
Net Margin = 3.78% (Net Income TTM 1.21b / Revenue TTM 31.87b)
Gross Margin = 73.24% ((Revenue TTM 31.87b - Cost of Revenue TTM 8.53b) / Revenue TTM)
Gross Margin QoQ = 72.25% (prev 73.01%)
Tobins Q-Ratio = 1.22 (Enterprise Value 50.21b / Total Assets 41.18b)
Interest Expense / Debt = 1.33% (Interest Expense 314.0m / Debt 23.60b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 5.27b (EBIT 7.03b * (1 - 25.00%))
Current Ratio = 1.34 (Total Current Assets 10.76b / Total Current Liabilities 8.05b)
Debt / Equity = 1.60 (Debt 23.60b / totalStockholderEquity, last quarter 14.71b)
Debt / EBITDA = 1.72 (Net Debt 19.28b / EBITDA 11.19b)
Debt / FCF = 6.28 (Net Debt 19.28b / FCF TTM 3.07b)
Total Stockholder Equity = 14.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.92% (Net Income 1.21b / Total Assets 41.18b)
RoE = 8.13% (Net Income TTM 1.21b / Total Stockholder Equity 14.82b)
RoCE = 27.99% (EBIT 7.03b / Capital Employed (Equity 14.82b + L.T.Debt 10.31b))
RoIC = 18.82% (NOPAT 5.27b / Invested Capital 28.03b)
WACC = 5.38% (E(30.92b)/V(54.52b) * Re(8.73%) + D(23.60b)/V(54.52b) * Rd(1.33%) * (1-Tc(0.25)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.19%
[DCF] Terminal Value 83.67% ; FCFF base≈3.09b ; Y1≈2.46b ; Y5≈1.64b
[DCF] Fair Price = 253.7 (EV 50.40b - Net Debt 19.28b = Equity 31.11b / Shares 122.6m; r=6.0% [WACC]; 5y FCF grow -24.62% → 3.0% )
EPS Correlation: -27.43 | EPS CAGR: -69.17% | SUE: 0.0 | # QB: 0
Revenue Correlation: -45.21 | Revenue CAGR: -5.48% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=6.87 | Chg7d=-0.200 | Chg30d=-0.394 | Revisions Net=-11 | Growth EPS=+58.7% | Growth Revenue=+1.6%
EPS next Year (2027-12-31): EPS=10.33 | Chg7d=-0.200 | Chg30d=-0.510 | Revisions Net=-7 | Growth EPS=+50.4% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 11 Down within 30d for Current Year)